14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $16.16 $18.63 Thursday, 25th Apr 2024 ACAD stock ended at $16.31. This is 1.69% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.17% from a day low at $16.16 to a day high of $16.51.
90 days $16.16 $27.94
52 weeks $16.16 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Nov 30, 2023 $22.40 $22.49 $22.03 $22.28 1 316 670
Nov 29, 2023 $22.40 $22.50 $22.03 $22.13 750 728
Nov 28, 2023 $22.16 $22.29 $21.87 $22.29 927 384
Nov 27, 2023 $22.19 $22.28 $21.59 $22.12 881 878
Nov 24, 2023 $22.02 $22.30 $21.86 $22.29 528 656
Nov 22, 2023 $22.27 $22.45 $21.86 $21.99 1 172 020
Nov 21, 2023 $22.76 $22.91 $22.37 $22.45 873 710
Nov 20, 2023 $22.64 $22.94 $22.54 $22.92 865 459
Nov 17, 2023 $22.29 $22.86 $22.15 $22.84 1 182 359
Nov 16, 2023 $22.46 $22.63 $21.82 $22.07 964 420
Nov 15, 2023 $23.17 $23.39 $22.57 $22.57 964 098
Nov 14, 2023 $23.14 $23.26 $22.85 $23.20 1 561 843
Nov 13, 2023 $22.07 $22.46 $21.80 $22.42 1 093 270
Nov 10, 2023 $22.18 $22.39 $21.58 $22.20 1 393 378
Nov 09, 2023 $23.27 $23.32 $21.83 $22.01 1 598 708
Nov 08, 2023 $23.54 $23.83 $22.86 $23.19 1 264 245
Nov 07, 2023 $23.99 $24.05 $23.34 $23.50 1 530 070
Nov 06, 2023 $25.10 $25.55 $23.57 $23.98 2 184 754
Nov 03, 2023 $24.00 $24.72 $22.78 $24.07 2 694 495
Nov 02, 2023 $22.91 $23.02 $22.50 $22.99 1 555 942
Nov 01, 2023 $22.67 $23.00 $22.36 $22.92 1 576 248
Oct 31, 2023 $22.05 $23.00 $21.94 $22.57 1 171 765
Oct 30, 2023 $21.97 $22.40 $21.90 $22.23 811 536
Oct 27, 2023 $22.57 $22.69 $21.65 $21.76 1 157 456
Oct 26, 2023 $22.56 $22.99 $22.00 $22.50 1 585 258
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT